JPMorgan Raises Calix Price Target to $90 as Shares Gap Up to $59.78
JPMorgan upgraded Calix from neutral to overweight and raised its price target to $90 from $75, driving shares to gap up from $54.96 to $59.78 before market open. Insider directors sold a combined 470,000 shares at average prices of $64.09–$65.34, netting $30.2 million and cutting their holdings by 19.87%.
1. Shares Surge on Heavy Trading Volume
Calix shares jumped 7.4% in the most recent trading session, with daily volume reaching more than 150,000 shares, compared to an average of approximately 90,000. The increase followed better-than-expected third-quarter results, where revenue rose by 32.1% year-over-year to $265.4 million and EPS came in at $0.44, beating consensus estimates by $0.10.
2. Analyst Upgrade Drives Positive Outlook
JPMorgan Chase upgraded Calix from neutral to overweight, raising its target by 20% to a level representing a potential one-year upside of roughly 50%. This followed similar bullish actions by UBS, Needham and Roth Capital, all of which maintain buy or outperform ratings with targets clustered between mid-80s and low-90s. Consensus among nine sell-side analysts shows six buys, two holds and one sell, translating to a moderate buy consensus.
3. Insider and Institutional Moves Underline Confidence Shift
Insiders sold a combined 530,000 shares last quarter, representing nearly 17% of insider-owned stock, while large institutions adjusted holdings—SouthState increased its stake by 10,000%, Clearstead Advisors by 139.3%, and Whittier Trust by 541.0%. These moves reflect active repositioning ahead of fourth-quarter guidance of EPS between $0.35 and $0.41, while institutional ownership remains above 98%.